Patent Opposition Database

Hide annotations

No Annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): AR115578A1
Who filed: CILFA
Country: Argentina
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 31-03-2021
Patent type: Compositions

Add an annotation

Where in the document

Click within the document, or manually enter the page number below

10 similar patent oppositions

CILFA opposition, semaglutide, (AR114353A1)

Countries: Argentina Date: 2021
CILFA opposition, osimertinib, (AR115019A2)

Countries: Argentina Date: 2021
CILFA opposition, linaclotide, (AR118601A2)

Countries: Argentina Date: 2021
CILFA opposition, celecoxib, (P990106069)

Countries: Argentina Date: 2004
CILFA opposition, carvedilol+hydrochlorothiazide, (P990105974)

Countries: Argentina Date: 2002
CILFA opposition, Nadifloxacin, (P990106490)

Countries: Argentina Date: 2002
CILFA opposition, fexofenadine+cyclodextrins, (P990105185)

Countries: Argentina Date: 2002
CILFA opposition, descarboetoxiloratadina, (P000103667 divisional of P990103342)

Countries: Argentina Date: 2002
CILFA opposition, descarboetoxiloratadina + fosfatodibásico de calcio, (P000103668 divisional of P990103342)

Countries: Argentina Date: 2002
CILFA opposition, Gamma-aminobutiric acid derivatives including gabapentin , pregabalin, baclofen, (P990102313)

Countries: Argentina Date: 2002